Application of triple quadrupole mass spectrometry for the characterization of antibody–drug conjugates
Open Access
- 8 March 2019
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 411 (12) , 2569-2576
Abstract
Antibody–drug conjugates (ADCs) are an inherently heterogeneous class of biotherapeutics, the development of which requires extensive characterization throughout. During the earliest phases of preclinical development, when synthetic routes towards the desired conjugate are being assessed, the main interest lies in the determination of the average drug-to-antibody ratio (DAR) of a given batch as well as information about different conjugation species. There has been a trend in mass spectrometry (MS)–based characterization of ADCs towards the use of high-resolving mass spectrometry for many of these analyses. Considering the high cost for such an instrument, the evaluation of cheaper and more accessible alternatives is highly motivated. We have therefore tested the applicability of a quadrupole mass analyzer for the aforementioned characterizations. Eight ADCs consisting of trastuzumab and varying stoichiometries of Mc-Val-Cit-PABC-monomethyl auristatin E conjugated to native cysteines were synthesized and served as test analytes. The average DAR value and molecular weights (Mw) of all detected chains from the quadrupole mass analyzer showed surprisingly high agreement with results obtained from a time-of-flight (TOF) mass analyzer and hydrophobic interaction chromatography (HIC)–derived values for all investigated ADC batches. Acquired Mw were within 80 ppm of TOF-derived values, and DAR was on average within 0.32 DAR units of HIC-derived values. Quadrupole mass spectrometers therefore represent a viable alternative for the characterization of ADC in early-stage development.Keywords
Funding Information
- Uppsala Universitet
This publication has 27 references indexed in Scilit:
- Advances in native high‐performance liquid chromatography and intact mass spectrometry for the characterization of biopharmaceutical productsJournal of Separation Science, 2017
- Approaches to Interchain Cysteine-Linked ADC Characterization by Mass SpectrometryMolecular Pharmaceutics, 2014
- Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution AssessmentAnalytical Chemistry, 2014
- Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometryTrAC Trends in Analytical Chemistry, 2013
- Analytical and bioanalytical technologies for characterizing antibody–drug conjugatesCurrent Opinion in Chemical Biology, 2013
- Antibody-Drug Conjugates2013
- Antibody-Drug Conjugates and Immunotoxins2013
- Antibody‐Drug Conjugates for the Treatment of CancerChemical Biology & Drug Design, 2012
- Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine ResiduesAnalytical Chemistry, 2012
- Comparison between a high‐resolution single‐stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugsRapid Communications in Mass Spectrometry, 2012